| Prev Close: | 3.96 |
|---|---|
| Open: | 3.86 |
| Bid: | 4.12 x 6600 |
| Ask: | 4.13 x 33400 |
| 1y Target Est: | 5.79 |
| Beta: | 2.92 |
| Next Earnings Date: | 5-Aug-13 |
| Day's Range: | 3.77 - 4.13 |
|---|---|
| 52wk Range: | 2.25 - 4.40 |
| Volume: | 698,261 |
| Avg Vol (3m): | 676,729 |
| Market Cap: | 342.35M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.88 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- XOMA CORP FinancialsEDGAR Online Financials(Tue May 14)
- 3 Humongous Health-Care Stocks This Weekat Motley Fool(Sat May 11)
- XOMA Management Presents at Credit Suisse 2013 Antibody Day (Transcript)at Seeking Alpha(Fri May 10)
- Positive Data on Celgene's ApremilastZacks(Thu May 9)
- ARNA Sheds Light on Belviq LaunchZacks(Thu May 9)
- XOMA price target raised to $6 from $5 at Ladenburgtheflyonthewall.com(Thu May 9)
- Stock Upgrades: Green Mountain Scales the Summitat Minyanville(Thu May 9)
- VIVUS Reports Wider LossZacks(Thu May 9)
- XOMA Corp CEO Discuses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Wed May 8)
- XOMA Highlights Recent Achievements and Reports Financial Results for First Quarter 2013GlobeNewswire(Wed May 8)
- XOMA CORP Files SEC form 10-Q, Quarterly ReportEDGAR Online(Wed May 8)
- Q1 2013 XOMA Earnings Release - After Market CloseCCBN(Wed May 8)
- XOMA to Present at Credit Suisse 2013 Antibody DayGlobeNewswire(Mon May 6)
- Incremental Changes in Regulatory Environment Beneficial to Development-Stage Biotech Companies Due to Emphasis on Closer Working Relationships with the FDA and Drug SponsorsWall Street Transcript(Wed May 1)
- CHMP Backs VIVUS' SpedraZacks(Tue Apr 30)
Press Releases
- XOMA Highlights Recent Achievements and Reports Financial Results for First Quarter 2013GlobeNewswire(Wed May 8)
- XOMA to Present at Credit Suisse 2013 Antibody DayGlobeNewswire(Mon May 6)
- XOMA to Announce First Quarter 2013 Financial Results and Host Webcast on May 8GlobeNewswire(Thu Apr 25)
Must Read
- J&J aims to seek approval for more than 10 new drugs by 2017, including for pain, depressionThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- 87-year-old woman loses to Donald Trump at trial alleging bait and switch by 'Apprentice' starThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- Mobilicity takes first step to be acquired by Telus but approvals neededThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- TSX, U.S. indexes fall as world markets plunge on Chinese manufacturing dataThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- Ally to pay $2.1 billion to settle claims tied to ResCapReuters(1969-12-31T18:59:59GMT-05:00)